证券日报网讯11月28日晚间，键邦股份（603285）发布公告称，公司计划使用自有资金，以集中竞价交 易方式回购公司股份，本次回购的股份将用于股权激励或员工持股计划。回购股份金额：不低于人民币 1，500.00万元(含)，不超过人民币3，000.00万元(含)；回购股份价格：不超过人民币38.00元/股(含)； 回购股份期限：自公司董事会审议通过本次回购方案之日起不超过12个月。 ...

Group 1 - Jianbang Co., Ltd. plans to repurchase shares using self-owned funds between 15 million and 30 million yuan, with a maximum price of 38 yuan per share [1] - Yatong Precision Engineering's investment in a private equity fund has been terminated due to failure to complete the agreed investment, leading to the fund's dissolution [1] - China Storage Co., Ltd. intends to invest 1.129 billion yuan in the Sanjiang Port project, with its wholly-owned subsidiary contributing 500 million yuan to establish a project company [2] Group 2 - Guangxin Co., Ltd. plans to inject assets worth 4.383 billion yuan into its wholly-owned subsidiary, increasing its registered capital from 10 million to 20 million yuan [3] - Jiangxin Home plans to use up to 3 billion yuan of idle self-owned funds for cash management in low-risk financial products [4] - Huangshan Tourism intends to lease part of the Huangshan scenic area for 1.27 billion yuan over a 10-year period [5] Group 3 - Jilin Expressway's general manager has resigned due to work adjustments [6] - Guoyao Modern's subsidiary has received a drug registration certificate for hydromorphone hydrochloride injection, suitable for pain management [8] - Hangya Technology plans to invest up to 70 million USD to establish subsidiaries in Singapore and Malaysia [10] Group 4 - ST Sailong's subsidiary has received approval for the listing of two chemical raw materials [11] - Shanghai Pharmaceuticals' tramadol hydrochloride injection has passed the consistency evaluation for generic drugs [12] - Yubang Electric has obtained a laboratory accreditation certificate from CNAS, indicating its testing capabilities [14] Group 5 - ST Lifang's stock will be subject to delisting risk warning starting December 1 due to administrative penalties [15] - Zhejiang Longsheng is investing 200 million yuan in a private equity partnership focused on high-potential enterprises [15] - Huayang Co., Ltd.'s subsidiary has obtained safety production permits, allowing it to commence production [16] Group 6 - Xujie Electric has won a bid for a State Grid project worth 1.518 billion yuan [17] - Pinggao Electric and its subsidiaries have collectively won a State Grid project worth approximately 773 million yuan [17] - ST Lanhua's subsidiary has entered the trial production phase for a juice beverage project with a total investment of up to 65 million yuan [18] Group 7 - Huakong Saige has terminated its stock issuance plan due to various considerations [19] - Yatong Co., Ltd. plans to invest 36 million yuan to establish a joint venture in renewable energy [20] - Warner Pharmaceuticals has received a drug registration certificate for a new inhalation solution for COPD patients [21] Group 8 - Demais has raised the upper limit for its share repurchase price to 45 yuan per share [22] - China West Electric's subsidiaries have collectively won a State Grid procurement project worth approximately 2.98 billion yuan [22] - Changan Automobile's joint venture has submitted a listing application to the Hong Kong Stock Exchange [23] Group 9 - Yinlun Co., Ltd. plans to invest approximately 133 million yuan to acquire a controlling stake in Shenzhen Deep Blue Electronics [24] - Zhongfu Information intends to increase its wholly-owned subsidiary's capital by 380 million yuan [24] - Financial Street's major shareholder has reduced its stake by 0.25% [25] Group 10 - Audiwei has formally submitted an application for H-share listing [26] - Zhongcai Technology's private placement application has been accepted by the Shenzhen Stock Exchange [27] - Haowei Group's subsidiary plans to invest 200 million yuan in a private equity fund focused on semiconductor investments [28] Group 11 - Jinkai New Energy is planning to transfer 51% of its subsidiary's equity to introduce strategic investors [31] - Huafeng Technology has reduced its fundraising target for a private placement to no more than 972 million yuan [32] - Mindray Medical's chairman plans to increase his stake in the company by 200 million yuan [33] Group 12 - Zhongman Petroleum's shareholders plan to reduce their holdings by up to 3% [35] - Innovation New Materials' shareholder intends to reduce their stake by up to 1% [37] - Guangdong Construction has signed a framework agreement to establish a quality testing base in Linzhi Economic Development Zone [39]

智通财经APP讯，键邦股份(603285.SH)发布公告，公司拟1500万元至3000万元回购公司股份，回购价 格不超过38元/股，回购的股份将在未来适宜时机用于实施员工持股计划或者股权激励。 ...

键邦股份（603285）(603285.SH)发布公告，公司拟1500万元至3000万元回购公司股份，回购价格不超 过38元/股，回购的股份将在未来适宜时机用于实施员工持股计划或者股权激励。 ...

格隆汇11月28日丨键邦股份(603285.SH)公布,基于对公司未来持续稳定发展的信心和对公司长期价值的 认可，为进一步健全公司长效激励机制，充分调动公司员工积极性，结合公司经营情况及财务状况等因 素，依据相关规定，公司计划使用自有资金，以集中竞价交易方式回购公司股份。回购股份金额：不低 于人民币1500.00万元(含)，不超过人民币3000.00万元(含)。回购股份价格：不超过人民币38.00元/股 (含)，该价格未超过公司董事会审议通过相关决议前30个交易日公司股票交易均价的150%。本次回购的 股份将用于股权激励或员工持股计划。 来源：格隆汇APP ...

重要内容提示： ●相关股东是否存在减持计划：经问询，截至 2025 年 11 月 28 日，公司董事、高 级管理人员、控股股东、实际控制人及一致行动人、持股 5%以上的股东未来 3 个 月、未来 6 个月不存在减持公司股份的计划。 ●相关风险提示： ●回购股份金额：不低于人民币 1,500.00 万元（含），不超过人民币 3,000.00 万元 （含）。 ●回购股份资金来源：山东键邦新材料股份有限公司（以下简称"公司"）自有资 金 ●回购股份用途：本次回购的股份将在未来适宜时机用于实施员工持股计划或者股 权激励，并在公司披露股份回购实施结果暨股份变动公告日之后的三年内予以转 让；若公司本次回购的股份未能在上述三年内转让完毕，公司将依法履行减少注 册资本的程序，未转让股份将在三年期限届满前注销。如国家对相关政策作出调 整，则本回购方案按调整后的政策实行。 ●回购股份价格：不超过人民币 38.00 元/股（含），该价格未超过公司董事会审议 通过相关决议前 30 个交易日公司股票交易均价的 150%。 ●回购股份方式：集中竞价交易方式。 ●回购股份期限：自公司董事会审议通过本次回购方案之日起不超过 12 个月。 证 ...

人民财讯11月28日电，键邦股份（603285）11月28日公告，公司计划使用自有资金，不低于1500万元 (含)，不超过3000万元(含)，以集中竞价交易方式回购公司股份，本次回购的股份将用于股权激励或员 工持股计划。回购股份价格不超过38元/股(含)，该价格未超过公司董事会审议通过相关决议前30个交易 日公司股票交易均价的150%。 ...

键邦股份公告，拟以1500万元-3000万元回购公司股份，回购价格不超过38元/股。 ...

键邦股份11月28日公告，公司计划使用自有资金，以集中竞价交易方式回购公司股份，回购金额不低于 1500万元（含），不超过3000万元（含）。回购的股份将在未来适宜时机用于实施员工持股计划或者股 权激励。 ...

Group 1 - The core viewpoint of the news is that Jianbang Co., Ltd. experienced a decline in stock price and significant changes in financing activities on November 18, with a net financing outflow of 317.31 million yuan [1] - On November 18, Jianbang Co., Ltd. had a trading volume of 62.26 million yuan, with a financing buy-in of 4.00 million yuan and a financing repayment of 7.18 million yuan, resulting in a total financing balance of 98.07 million yuan, which accounts for 6.17% of the circulating market value [1] - The company is engaged in the research, production, and sales of polymer material environmental additives, with its main business revenue composition being 50.12% from Saike, 23.73% from DBM/SBM, 14.67% from titanate, 8.93% from acetylacetone salt, and 2.56% from other sources [1] Group 2 - As of September 30, Jianbang Co., Ltd. had 15,400 shareholders, an increase of 0.12% from the previous period, with an average of 4,042 circulating shares per person, which is an increase of 55.56% [2] - For the period from January to September 2025, Jianbang Co., Ltd. reported operating revenue of 469 million yuan, a year-on-year decrease of 9.45%, and a net profit attributable to the parent company of 107 million yuan, down 17.71% year-on-year [2] - The company has distributed a total of 192 million yuan in dividends since its A-share listing [3]